• "A collaboration of NASA Ames Research Center, industry, and local universities is developing a fully-automated, miniaturized spaceflight system that provides life support and nutrient delivery, and performs assays for genetic changes E. coli. Flying multiple missions as a secondary payload using this low-cost approach will lead to better understanding of the biological effects of the spaceflight environment, particularly space radiation and reduced gravity, enabling countermeasure development, which is a critical need for safe long-duration crewed space missions and safe space tourism."
  • "After PharmaSat separates from the Minotaur 1 rocket and successfully enters low Earth orbit at approximately 285 miles above the Earth, it will activate and begin transmitting radio signals to two ground control stations. The primary ground station at SRI International, Menlo Park, Calif., will transmit mission data from the satellite to the spacecraft operators in the mission control center at NASA's Ames Research Center, Moffett Field, Calif. A secondary station is located at Santa Clara University, Santa Clara, Calif. When NASA spaceflight engineers make contact with PharmaSat, which could happen as soon as one hour after launch, the satellite will receive a command to initiate its experiment, which will last 96 hours. Once the experiment begins, PharmaSat will relay data in near real-time up to six months, to mission managers, engineers and project scientists for further analysis."
  • "As a follow on to the highly successful GeneSat-1 Mission, the Ames Small Spacecraft Division is collaborating with industry and local universities to develop the next generation fully-automated, miniaturized triple cubesat spaceflight system for biological payloads. The PharmaSat experiment and flight system will be designed to measure the influence of microgravity upon yeast resistance to an antifungal agent. PharmaSat implements PI guided science focused on questions key to countermeasure development for long-term space travel and habitation….

    The use of low-cost, small-size, autonomous secondary payload concepts provides a means to study biological changes of fundamentally well-understood microorganisms and mammalian cells at the gene/protein level."

  • "Microgravity can impact living organisms in a variety of ways, and now NASA researchers want to find out how it affects pharmaceuticals. On May 5, a small satellite about the size of a loaf of bread will launch as a secondary payload on a U.S. Air Force Minotaur 1 rocket. Weighing in at about 10 pounds, the nanosatellite — called PharmaSat — houses a micro-laboratory with sensors that can detect the growth, density, and health of yeast cells. When NASA spaceflight engineers make contact with PharmaSat, which could happen as soon as one hour after launch, they will send a command to the satellite to initiate a 96-hour experiment, which involves administering an antifungal treatment to yeast cells at three dosage levels."

  • "KentuckySpace is a non-profit enterprise involving a consortium of universities and private organizations for the purpose of pursuing space-related education, R&D, small satellite design and launch operations."

    (tags: space cubesat)

  • "Nine years of work disappeared in five minutes yesterday when a NASA satellite crashed into the icy waters near Antarctica. Now climate scientists who worked on the ambitious effort to map the world's carbon dioxide are trying to figure out what comes next."